- 中国精品科技期刊
- 中国高校百佳科技期刊
- 中国中文核心期刊
- 中国科学引文数据库核心期刊
| Citation: |
JIANG Yun, LEI Yajuan, XIE Yingying, et al. Screening of 12 elemental impurities in pharmaceutical excipient grades of titanium dioxide from various sources and their correlations with whiteness[J]. J China Pharm Univ, 2024, 55(6): 750 − 757. DOI: 10.11665/j.issn.1000-5048.2023122803
|
In the process of promoting the implementation and transformation of the Q3D guideline of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) in China, the risk assessment of elemental impurities in naturally sourced excipients often faces challenges such as multiple types of elemental impurities and insufficient detection methods. In this paper, an inductively coupled plasma mass spectrometry (ICP-MS) method for screening 12 elemental impurities in titanium dioxide was established using the optimized acid extraction pre-treatment method. The accuracy and repeatability of the method were good. The recoveries of cadmium, lead, mercury, cobalt, nickel, lithium, barium, molybdenum, copper, chromium and iron were 83.6%−101.6%, the recovery of antimony was 54.1%, and the RSD was 1.1%−10.2% (n=6). The evaluation results of elemental impurities showed that the risk of cadmium, mercury, cobalt, nickel, lithium, barium, molybdenum, copper, chromium and antimony was low, while the risk of lead was high, and it is recommended that a lead salt test be added to the pharmacopoeia standard for this product. Based on the statistical data, the differences in the control levels of elemental impurities and whiteness of 29 batches of titanium dioxide samples from 10 domestic and foreign manufacturers were compared and analyzed. The Pearson correlation coefficient method was used to analyze the correlation between residual elemental impurities and whiteness, and a heat map was used to visualize the results. The results showed that whiteness was significantly negatively correlated with the amount of residual barium and the sum of residual elemental impurities. It is suggested that the manufactures should include whiteness as an internally controlled indicator to further improve the quality of titanium dioxide used as a pharmaceutical excipient.
| [1] |
Zhang HM, Yu LZ, Chen X, et al. New standard and method for elemental impurities control in and new general rules of USP and effects of them on pharmaceutical industry[J]. China Pharm (中国药房), 2014, 25(17): 1601-1604.
|
| [2] |
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. ICH Q3D(R2): Guideline for elemental impurities. [EB/0L]. (2022-04-26)[2023-12-24]. https://database.ich.org/sites/default/files/Q3D-R2_Guideline_Step4_2022_0308.pdf.
|
| [3] |
European Directorate for the Quality of Medicines & Healthcare. European Pharmacopeia 11.2 (欧洲药典11.2)[S]. France: European Directorate for the Quality of Medicine & Healthcare, 2023: 4966-4967.
|
| [4] |
The United States Pharmacopeia Convention. Monograph: Titanium Dioxide. In: USP–NF(美国药典-国家处方集)[S], Rockville: The United StatesPharmacopeial Convention, 2023: 1-2.
|
| [5] |
Pharmaceutical and Medical Device Regulatory Science Society of Japan. Japanese Pharmacopoeia XⅧ(日本药局方18 版) [S], Tokyo: Pharmaceutical and Medical Device Regulatory Science Society of Japan, 2021: 1835-1836.
|
| [6] |
Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients(药用辅料手册)[M] . 6th ed. London: Pharmaceutical Press, 2009: 741-744.
|
| [7] |
Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia: part 4 (中华人民共和国药典: 四部) [S]. Beijing: China Medical Science Press, 2020: 579-580.
|
| [8] |
The United States Food and Drug Administration. The Electronic Code of Federal Regulations: Titanium dioxide (section 73.575 of 21 CFR). [EB/0L]. (2001-12-27)[2023-12-24]. https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-73/subpart-A/section-73.575.
|
| [9] |
Huang DG, Liao SJ, Zhang XQ, et al. Study on the method for the determination of impurities in titanium dioxide by ICP-MS[J]. J Anal Sci (分析科学学报), 2005, 21(4): 423-425.
|
| [10] |
Cheng Y. Determination of micro impurity elements in the titanium dioxide by inductively coupled plasma-atomic emission spectrometry with microwave digestion[J]. Metall Anal (冶金分析), 2006, 26(2): 57-60.
|
| [11] |
European Directorate for the Quality of Medicines & Healthcare. European Pharmacopeia 10.0 (欧洲药典10.0)[S].France:European Directorate for the Quality of Medicine & Healthcare, 2022: 4052-4053.
European Directorate for the Quality of Medicines & Healthcare. European Pharmacopeia 10.0 (欧洲药典10.0)[S].France:European Directorate for the Quality of Medicine & Healthcare, 2022: 4052-4053.
|
| [12] |
Wani AL, Ara A, Usmani JA. Lead toxicity: a review[J]. Interdiscip Toxicol, 2015, 8(2): 55-64.
|
| [13] |
Zhao XX, Zhao ZS, Chen C, et al. Study on selection of internal standard element of ICP-MS[J]. Environ. Monit. China (中国环境监测), 2016, 32(1): 84-87.
Zhao XX, Zhao ZS, Chen C, et al. Study on selection of internal standard element of ICP-MS[J]. Environ. Monit. China (中国环境监测), 2016, 32(1): 84-87.
|
| [14] |
Vanhaecke F, Vanhoe H, Dams R, et al. The use of internal standards in ICP-MS[J]. Talanta, 1992, 39(7): 737-742.
|
| [15] |
Li Z, Wu Y, Nie JJ, et al. Determination of twenty-four elemental impurities in gadopentetate dimeglumine by ICP-MS with matrix-matching method[J]. Chin J Pharm (中国医药工业杂志), 2022, 53(9): 1311-1317.
Li Z, Wu Y, Nie JJ, et al. Determination of twenty-four elemental impurities in gadopentetate dimeglumine by ICP-MS with matrix-matching method[J]. Chin J Pharm (中国医药工业杂志), 2022, 53(9): 1311-1317.
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Total visits：312130
DownLoad: